190 related articles for article (PubMed ID: 6347771)
1. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
2. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
3. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
4. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
[TBL] [Abstract][Full Text] [Related]
5. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
[TBL] [Abstract][Full Text] [Related]
6. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
Elamin A; Omer MI; Tuvemo T
Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
[TBL] [Abstract][Full Text] [Related]
7. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
Majkowska L; Czekalski S; Skwira J
Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics.
Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S
Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes.
Sensi M; Zuccarini O; Spencer KM; Beales P; Pujol-Borrell R; Pozzilli P
Diabetes Res; 1985 Jan; 2(1):1-4. PubMed ID: 3888494
[TBL] [Abstract][Full Text] [Related]
10. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
Brown FM; Kamalesh M; Adri MN; Rabinowe SL
Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
[TBL] [Abstract][Full Text] [Related]
11. Relationship of islet cell and islet cell surface antibodies to the presentation and early course of IDDM in childhood.
Daneman D; Sochett E; Pak CY; Yoon JW
Diabetes Res Clin Pract; 1988 Jan; 4(2):127-32. PubMed ID: 3277828
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of various types of islet cell antibodies in diabetes as a function of its cause and duration].
Vialettes B; Di Campo-Rougerie C; Lassmann V; Vague P
Presse Med; 1983 Oct; 12(37):2303-6. PubMed ID: 6226978
[TBL] [Abstract][Full Text] [Related]
13. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
14. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
Samuelsson U; Ludvigsson J; Sundkvist G
Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
[TBL] [Abstract][Full Text] [Related]
15. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
16. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiologic studies of the recognition of the preclinical phase of type I diabetes in school children].
Seissler J; Glück M; Speck U; Yassin N; Fetzer A; Bornstein S; Hauner H; Heinze E; Scherbaum WA
Dtsch Med Wochenschr; 1990 May; 115(18):689-94. PubMed ID: 2185925
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
[TBL] [Abstract][Full Text] [Related]
19. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
Di Mario U; Irvine WJ; Borsey DQ; Kyner JL; Weston J; Galfo C
Diabetologia; 1983 Nov; 25(5):392-5. PubMed ID: 6360778
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
